The easy transplantation of cornea from a donor to any recipient even when the transplantation process is risky due to rejection by the immune system. Introduction: MHC (Major histocompatibility complex) is an assembly of genes that encodes for the surface proteins that are important for the acquired immune system to identify the foreign particle that in turn determines the histocompatibility. They display the antigen on the surface and make it available for the T cells (Thymic lymphocyte) for interaction. These are present on the surface of platelets and nucleated cells but absent on RBCs (Red blood cells). These MHC proteins are present in most of the higher vertebrates.

Question

Want to see the full answer?

Answer 1

Question

Chapter 24.3, Problem 2TQ

Summary Introduction

To review:

The easy transplantation of cornea from a donor to any recipient even when the transplantation process is risky due to rejection by the immune system.

Introduction:

MHC (Major histocompatibility complex) is an assembly of genes that encodes for the surface proteins that are important for the acquired immune system to identify the foreign particle that in turn determines the histocompatibility. They display the antigen on the surface and make it available for the T cells (Thymic lymphocyte) for interaction. These are present on the surface of platelets and nucleated cells but absent on RBCs (Red blood cells). These MHC proteins are present in most of the higher vertebrates.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

C MasteringHealth MasteringNu × session.healthandnutrition-mastering.pearson.com/myct/itemView?assignment ProblemID=17465255&attemptNo=1&offset=prev

Biopharmaceutics and Pharmacokinetics:Two-Compartment Model Instant Absorption Questions SHOW ALL WORK, including equation used, variables used and each step to your solution, report your regression lines and axes names (with units if appropriate) :Calculate a-q a) B1, b) B2, c) hybrid rate constant (1) d) hybrid rate constant (2) e) t1/2,dist f) t1/2,elim g) k10 h) k12 i) k21 j) initial concentration (C0) k) central compartment volume (V1) l) steady-state volume (Vss) m) clearance (CL) AUC (0→10 min) using trapezoidal rule n) AUC (20→30 min) using trapezoidal rule o) AUCtail (AUC360→∞) p) total AUC (using short cut method) q) volume from AUC (VAUC)

Glitazones reduce insulin resistance by binding to a transcription factor in adipocytes, thereby reducing thesecretion of fatty acids. Glitazones are taken orally (in pill form). Using pharmacokinetic modeling, deriveequations to describe how the concentration of glitazones varies in the plasma as a function of time. Yourequations should be of the form: dCglitazone /dt = something, or dMglitazone /dt = something. Your model shouldinclude three compartments: the gut, the plasma, and the fatty tissues. Make sure to include a diagram thatillustrates your thinking, state all assumptions, and define your variables. Do not solve the equations.